TITLE

Modeling of human M1 aminopeptidases for in silico screening of potential Plasmodium falciparum alanine aminopeptidase (PfA-M1) specific inhibitors

AUTHOR(S)
Sahi, Shakti; Rai, Sneha; Chaudhary, Meenakshi; Nain, Vikrant
PUB. DATE
August 2014
SOURCE
Bioinformation;2014, Vol. 10 Issue 8, p518
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Plasmodium falciparum alanine M1-aminopeptidase (PfA-M1) is a validated target for anti-malarial drug development. Presence of significant similarity between PfA-M1 and human M1-aminopeptidases, particularly within regions of enzyme active site leads to problem of non-specificity and off-target binding for known aminopeptidase inhibitors. Molecular docking based in silico screening approach for off-target binding has high potential but requires 3D-structure of all human M1-aminopeptidaes. Therefore, in the present study 3D structural models of seven human M1-aminopeptidases were developed. The robustness of docking parameters and quality of predicted human M1-aminopeptidases structural models was evaluated by stereochemical analysis and docking of their respective known inhibitors. The docking scores were in agreement with the inhibitory concentrations elucidated in enzyme assays of respective inhibitor enzyme combinations (r2≈0.70). Further docking analysis of fifteen potential PfA-M1 inhibitors (virtual screening identified) showed that three compounds had less docking affinity for human M1-aminopeptidases as compared to PfA-M1. These three identified potential lead compounds can be validated with enzyme assays and used as a scaffold for designing of new compounds with increased specificity towards PfA-M1.
ACCESSION #
98171144

 

Related Articles

  • REVIEW ON: INTRODUCTION TO NEW POTENTIAL ANTIMALARIAL DRUGS USED IN FALCIPARUM AND REVIEW OF VARIOUS ANALYTICAL METHODS FOR THEIR DETECTION FROM PHARMACEUTICAL FORMULATIONS. Shah, Nehal; Patel, Pinak // International Journal of Pharmacy & Pharmaceutical Sciences;Oct2012 Supplement, Vol. 4, p67 

    Current paper describes potential therapies available to treat falciparum which is the most common and fatal disease of endemic regions along with review of various chromatographic method available for their detection form various pharmaceutical formulations and from biological samples. It also...

  • A clinical trial with halofantrine on patients with falciparum malaria in Colombia. Restrepo, M.; Botero, D. // Bulletin of the World Health Organization;1996, Vol. 74 Issue 6, p591 

    Investigates the effect of halofantrine on patients with falciparum malaria in Colombia. Different treatment schedules; Doses of the drug; Obtaining the best results; Difference between relapsing and cured patients; Mild side-effects of the drug; Drug resistance levels; Electrocardiogram results.

  • Comparative Plasmodium falciparum Kinetics during Treatment with Amodiaquine and Chloroquine in Children. Sowunmi, A.; Falade, A.G.; Adedeji, A.A.; Ayede, A.I.; Fateye, B.A.; Sowunmi, C.O.; Oduola, A.M.J. // Clinical Drug Investigation;2001, Vol. 21 Issue 5, p371 

    Objectives: To examine the kinetics of the disposition of Plasmodium falciparum during treatment with amodiaquine, a Mannich base derivative of chloroquine and chloroquine. Additional aims were to compare P. falciparum kinetics in children in whom initial treatment with chloroquine failed and...

  • Exchange Transfusion as an Adjunct Therapy in Severe Plasmodium falciparum Malaria: A Meta-analysis. Riddle, Mark S.; Jackson, Jeffrey L.; Sanders, John W.; Blazes, David L. // Clinical Infectious Diseases;5/1/2002, Vol. 34 Issue 9, p1192 

    Focuses on a study which compared survival rates associated with adjunct exchange transfusion with those associated with antimalarial chemotherapy alone in patients with Plasmodium falciparum malaria. Materials and methods; Results; Discussion.

  • The Mechanisms of Parasite Clearance after Antimalarial Treatment of Plasmodium falciparum Malaria. Chotivanich, K.; Udomsangpetch, R.; Dondorp, A.; Williams, T.; Angus, B.; Simpson, J.A.; Pukrittayakamee, S.; Looareesuwan, S.; Newbold, C.I.; White, N.J. // Journal of Infectious Diseases;8/1/2000, Vol. 182 Issue 2 

    Examines the mechanism of parasite clearance after antimalarial treatment of Plasmodium falcifarum malaria. Analysis on the decrease of parasitized red cell deformation and the increase of antibody binding; Identification of the ring-infected erythrocyte surface antigen; Use of artesunate and...

  • Pyramax receives positive opinion from the EMA.  // Biomedical Market Newsletter;3/21/2012, Vol. 21, p1 

    The article reports that Pyramax, an antimalarial drug used for treatment against Plasmodium falciparum and blood-stage Plasmodium vivax malaria has received positive scientific opinion from the European Medicines Agency.

  • Pyronaridine�Artesunate versus Mefloquine plus Artesunate for Malaria. Rueangweerayut, Ronnatrai; Phyo, Aung Pyae; Uthaisin, Chirapong; Poravuth, Yi; Binh, Tran Quang; Tinto, Halidou; P�nali, Louis K.; Valecha, Neena; Tien, Nong Thi; Abdulla, Salim; Borghini-Fuhrer, Isabelle; Duparc, Stephan; Shin, Chang-Sik; Fleckenstein, Lawrence // New England Journal of Medicine;4/5/2012, Vol. 366 Issue 14, p1298 

    Background: Pyronaridine�artesunate is an artemisinin-based combination therapy under evaluation for the treatment of Plasmodium falciparum and P. vivax malaria. Methods: We conducted a phase 3, open-label, multicenter, noninferiority trial that included 1271 patients between 3 and 60 years...

  • Treatment of severe malaria. Warrell, D. A. // Journal of the Royal Society of Medicine (Supplement);Jul1989, Vol. 82 Issue 17, p44 

    In the treatment of severe Plasmodium falciparum infection antimalarial drugs should, ideally, be given by controlled rate intravenous infusion until the patient is able to swallow tablets. In cases where infection has been acquired in a chloroquine resistant area, and where it has broken...

  • Activities of artesunate and amodiaquine against intestinal helminth in children with Plasmodium falciparum malaria in endemic areas. Adedeji, A. A.; Fehintola, F. A.; Olasupo, N. O.; Balogun, T.; Sowunmi, A. // European Journal of Clinical Microbiology & Infectious Diseases;Jul2008, Vol. 27 Issue 7, p627 

    The article looks at the use of amodiaquine and artesunate in endemic areas to treat intestinal helminth in children with Plasmodium falciparum maralia. A study conducted in Ibadan, Nigeria is referenced. Children involved in the study were under the age of 13 and received supervised...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics